3 ms·
It's not a counterproductive limitation. In fact it should lead to more research: In this type of clinical experiment, if your data happens to show a significan
by ineedasername 8y ago
It's not a counterproductive limitation. In fact it should lead to more research: In this type of clinical experiment, if your data happens to show a significant result that wasn't in the pre-planned outcomes, the proper process to follow is to formulate a second course of research designed around validating that new hypothesis.
- BurningFrog 8y agoThat's a nice theory. I worry that in reality a lot of those second research projects will never happen.
- ineedasername 8y agoYou're right, it may not have had that result. But I think if the pharmaceutical companies had potentially significant results there would be a strong financial incentive to follow up with a another targeted study. It would be interesting to test, look and see whether the average number of trials per unit of time, probably year, increase after this change was made. I'm curious, but not enough to actually do the work :) Always more interesting question out there than time to follow up on them.